Side Effects of cytarabine: A Synthesis of Findings from 18 Studies
- Home
- Side Effects of cytarabine
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of cytarabine: A Synthesis of Findings from 18 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Cytarabine is a common chemotherapy drug used to treat various types of leukemia, but it can have serious side effects. Several studies have investigated ways to reduce cytarabine's side effects. For instance, 17 demonstrated that astaxanthin, a carotenoid with antioxidant, anti-inflammatory, and anticancer properties, can lower the dose of cytarabine required for leukemia treatment while reducing inflammation. 6 introduced a new antitumor agent called FA-HP-β-CyD, which triggers autophagic cell death in acute myeloid leukemia cells, potentially leading to fewer side effects compared to conventional chemotherapy. Additionally, 12 explored computational approaches to design prodrugs for cytarabine, aiming to improve its delivery and minimize side effects. Furthermore, 8 investigated the synergistic effect of combining cytarabine with adavosertib, a WEE1 inhibitor, resulting in significant alterations in metabolites related to cell survival, apoptosis, and cancer progression.
Reasons for Side Effects
Cytarabine's side effects stem from its mechanism of action: inhibiting DNA synthesis, which is vital for cell division. While this action targets rapidly dividing cancer cells, it also affects healthy cells, particularly those that replicate quickly, like bone marrow cells and cells lining the digestive tract.
General Side Effects
Digestive System
Cytarabine can affect digestive system cells, leading to side effects like nausea, vomiting, and diarrhea. These symptoms often appear within a few days of starting cytarabine. 2 found that cytarabine administration in Drosophila experiments resulted in intestinal damage and increased reactive oxygen species, suggesting that cytarabine can lead to damage in the intestines.
Hematopoietic System
Cytarabine's impact on bone marrow cells can result in decreased production of white blood cells, red blood cells, and platelets, increasing the risk of infections, anemia, and bleeding. This is especially significant as low white blood cell counts can increase the risk of fever and infections. Therefore, regular blood tests are crucial, and blood transfusions or antibiotics may be needed.
Nervous System
Cytarabine can affect brain nerve cells, potentially causing headaches, dizziness, and altered consciousness. These symptoms often appear within a few days of starting treatment. In severe cases, encephalopathy or coma may develop. 4 observed neuro-ophthalmological side effects, such as papilledema, in three adolescents with acute myeloid leukemia after intrathecal administration of liposomal cytarabine. The side effects resolved with prolonged dexamethasone therapy, suggesting the drug's impact on brain nerve cells.
Skin
Cytarabine can cause skin side effects like palmar-plantar erythrosis, which manifests as redness on the palms and soles. It often appears within a few days of starting cytarabine and typically resolves spontaneously within a few weeks. Additionally, 5 reported a case of cytarabine-induced ear erythema, demonstrating that cytarabine can affect the skin in various locations.
Other
Cytarabine can also affect other organs, such as the liver, kidneys, and heart, leading to decreased liver and kidney function or weakened heart function. The occurrence of these side effects varies depending on factors like the cytarabine dosage, duration of administration, patient's age, and overall health condition.
Measures to Counteract Side Effects
Digestive System
Antiemetics or anti-vomiting medications can help reduce gastrointestinal symptoms. Lifestyle modifications, such as dietary changes and sufficient hydration, are also beneficial. Gastrointestinal symptoms caused by cytarabine can vary based on the patient's health, cytarabine dosage, and administration method. Therefore, personalized approaches are necessary for each individual patient.
Hematopoietic System
Medications like granulocyte colony-stimulating factor (G-CSF) are used to prevent a decrease in white blood cell count. Additionally, preventive measures, such as wearing masks, frequent hand washing, and limiting unnecessary outings, are crucial to prevent infections. The decrease in white blood cell count caused by cytarabine can vary based on the individual's health, cytarabine dosage, and administration method, so personalized approaches are essential for each patient.
Nervous System
Steroid medications can help alleviate neurological symptoms. In severe cases of neurological symptoms, intensive care unit management may be required. Neurological symptoms caused by cytarabine vary depending on the patient's health, cytarabine dosage, and administration method, so personalized approaches are essential for each individual patient.
Skin
To mitigate skin side effects like palmar-plantar erythrosis, steroid ointments may be applied. Wearing gloves and socks can also help prevent symptom aggravation. Skin symptoms caused by cytarabine vary depending on the patient's health, cytarabine dosage, and administration method. Therefore, personalized approaches are necessary for each patient.
Other
If liver or kidney functions decrease, appropriate treatment is required. If heart function weakens, medications to reduce the heart's burden may be administered, or pacemakers may be implanted. Side effects caused by cytarabine vary depending on the individual's health, cytarabine dosage, and administration method. Therefore, personalized approaches are essential for each patient.
Comparison Across Studies
Commonalities Across Studies
Various studies have consistently shown that cytarabine can cause diverse side effects affecting the digestive system, hematopoietic system, nervous system, and skin. Moreover, these side effects vary depending on the cytarabine dosage, administration method, patient's age, and overall health condition.
Differences Across Studies
The frequency and severity of side effects caused by cytarabine can vary across studies. This is likely attributed to differences in the patient populations studied and cytarabine administration methods. For example, 3 found that pirarubicin combined with cytarabine therapy resulted in lower cardiotoxicity and hair loss rates compared to mitoxantrone combined with cytarabine therapy, and also reduced bone marrow suppression. Additionally, 18 reported a case of severe hypertriglyceridemia induced by PEG-asparaginase, highlighting the impact of various factors on cytarabine side effects.
Considerations for Real-World Applications
Cytarabine is a crucial drug for treating serious conditions like leukemia, but it can cause various side effects. It's essential to follow your doctor's instructions when taking cytarabine and seek immediate medical attention if you experience any side effects. Cytarabine is not suitable for use during pregnancy or breastfeeding. Additionally, older adults or individuals with kidney or liver dysfunction or other underlying medical conditions may require adjusted cytarabine dosages. Cytarabine side effects can vary greatly between individuals, so consulting your doctor beforehand and understanding the necessity and risks associated with its administration is crucial.
Limitations of Current Research
The underlying mechanisms of cytarabine-induced side effects and countermeasures to mitigate them are not fully understood. Additionally, cytarabine side effects can vary depending on each patient's health, making it difficult to predict their occurrence. Therefore, future research needs to investigate cytarabine side effects in more detail and develop new methods to alleviate them.
Future Research Directions
To thoroughly investigate cytarabine-induced side effects, various research efforts are necessary. For example, developing new drugs or treatment methods to reduce cytarabine side effects is essential. Molecular-level research focusing on genes, proteins, and other molecules is also crucial to understanding the mechanisms behind these side effects. Furthermore, as cytarabine side effects vary based on individual health, developing personalized treatment methods for each patient is paramount.
Conclusion
Cytarabine is an effective drug for treating serious illnesses such as leukemia, but it can potentially cause various side effects. It's vital to adhere to your doctor's instructions when taking cytarabine and seek immediate medical attention if you experience any side effects. Research is ongoing to mitigate cytarabine side effects, and the realization of safer cytarabine treatment is expected in the future.
Benefit Keywords
Risk Keywords
Article Type
Author: MahrleG, SchulzeH J, FärberL, WeidingerG, SteiglederG K
Language : English
Author: HanShuzhen, XiuMinghui, LiShuang, ShiYan, WangXiaoqian, LinXingyao, CaiHui, LiuYongqi, HeJianzheng
Language : English
Author: LvSuqin, LiAihua, WuHaijuan, WangXiaoli
Language : English
Author: SommerConstanze, LacknerHerwig, BeneschMartin, SovinzPetra, SchwingerWolfgang, MoserAndrea, BergloeffJutta, GruberAnna, UrbanChristian
Language : English
Author: BotrosMonica, De La RosaAlan, NadellaSahithi, ChangAymara Y, MaharajSatish S
Language : English
Author: KubotaYasushi, HoshikoToshimi, HigashiTaishi, MotoyamaKeiichi, OkadaSeiji, KimuraShinya
Language : English
Author: NedumannilRithin, BatterhamEmily, HardingEmily, RitchieDavid, WeiAndrew, BajelAshish
Language : English
Author: Rodríguez-VázquezGabriel O, Diaz-QuiñonesAdriana O, ChornaNataliya, Salgado-VillanuevaIris K, TangJing, OrtizWalter I Silva, MaldonadoHéctor M
Language : English
Author: AhernKatie, PhamJames, SandersonRobin, Correia De FariasMadson, WalshKevin
Language : English
Author: YaoHan, ZhangCheng, TanXu, LiJieping, YinXiaolin, DengXiaojuan, ChenTing, RaoJun, GaoLei, KongPeiyan, ZhangXi
Language : English
Author: JafariFatemeh, NodehMohammad Moeini, HosseinjaniHesamoddin, BahararaHamed, AzadSajad, ArastehOmid, JohnstonThomas P, SahebkarAmirhossein
Language : English
Author: BalouchMartin, StorchmannováKateřina, ŠtěpánekFrantišek, BerkaKarel
Language : English
Author: LiLei, TianHailong, ZhangZhe, DingNing, HeKai, LuShuaijun, LiuRuolan, WuPeijie, WangYu, HeBo, LuoMaochao, PengPeilan, YangMao, NiceEdouard C, HuangCanhua, XieNa, WangDong, GaoWei
Language : English
Author: ZektserMiri, RabinovichAnat, GrinbaumUri, PorgesTzvi, GozlanAya, GourevitchAnna, Al-AthamenKayed, BarrettOrit, PelesIdo, Kaisman-ElbazTehila, LeviEtai
Language : English
Author: GladbachYvonne Saara, SklarzLisa-Madeleine, RoolfCatrin, BeckJulia, SchützEkkehard, FuellenGeorg, JunghanssChristian, Murua EscobarHugo, HamedMohamed
Language : English
Author: MatthewsAndrew H, PerlAlexander E, LugerSelina M, LorenAlison W, GillSaar I, PorterDavid L, BabushokDaria V, MaillardIvan P, CarrollMartin P, FreyNoelle V, HexnerElizabeth O, MartinMary Ellen, McCurdyShannon R, StadtmauerEdward A, ParalkarVikram R, BrunoXimena Jordan, HwangWei-Ting, MargolisDavid, PratzKeith W
Language : English
Author: RastgarAmirhossein, SayadiMahtab, Anani-SarabGholamreza, SajjadiSeyed Mehdi
Language : English
Author: IannuzziArcangelo, AnnunziataMario, FortunatoGiuliana, GiacobbeCarola, PalmaDaniela, BrescianiAlessandro, AlibertiEmilio, IannuzzoGabriella
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.